PMDSF.US Pharma Foods International Co., Ltd.
- Market cap
- USD 186M
- P/E
- 8.4x
- P/B
- 2.41x
- ROE
- 15.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jul 2026.
Is PMDSF.US undervalued?
Graham numberPMDSF.US trades 5.1% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Pharma Foods International Co., Ltd. fundamental analysis
No fundamental analysis for Pharma Foods International Co., Ltd. yet.
Pharma Foods International Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Pharma Foods International Co., Ltd.
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. It also focuses on biomedical drug discovery of antibody and peptide drugs targeting diseases, including autoimmune, cancer, and inflammatory. The company was founded in 1997 and is headquartered in Kyoto, Japan.
Full company profilePharma Foods International Co., Ltd. financial statements
Pharma Foods International Co., Ltd. annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 60.2B | 68.6B | 62.1B | - | 63.2B |
| Gross Profit | 48.1B | 55.3B | 48.8B | - | 50.7B |
| Operating Income | 1.13B | 3.68B | 5.22B | 2.42B | 2.67B |
| EBITDA | 1.92B | 4.06B | 5.90B | 3.26B | 3.19B |
| Net Income | -374M | 3.08B | 3.21B | - | 1.99B |
| EPS | -13 | 107 | 114 | - | 68 |
| Balance Sheet | |||||
| Total Assets | 31.2B | 36.2B | 36.6B | - | 35.1B |
| Total Liabilities | 24.1B | 26.6B | 25.0B | - | 22.0B |
| Shareholders' Equity | 7.07B | 9.63B | 11.6B | - | 13.2B |
| Cash & Short-term Investments | 8.85B | 16.3B | 15.7B | - | 7.79B |
| Cash Flow | |||||
| Operating Cash Flow | -6.07B | 6.13B | 5.49B | - | -1.18B |
| Capital Expenditure | 472M | 405M | 973M | 0.00 | 4.03B |
| Free Cash Flow | -6.54B | 5.72B | 4.51B | - | -5.20B |
| Ratios | |||||
| ROE | -5.3% | 32.0% | 27.7% | - | 15.1% |
| ROA | -1.2% | 8.5% | 8.8% | - | 5.7% |
| Net Profit Margin | -0.6% | 4.5% | 5.2% | - | 3.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Pharma Foods International Co., Ltd. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- 36.4%
- Ex-dividend date
- Jan 28, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 723M | 25 | 36.4% |
| 2025 | - | - | - |
| 2024 | JPY 626M | 22 | 19.5% |
| 2023 | JPY 578M | 20 | 18.8% |
| 2022 | JPY 871M | 30 | - |
| 2021 | JPY 290M | 9.98 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Pharma Foods International Co., Ltd.
- Insiders 32.97%
- Institutions 7.87%
- Public & others 59.16%
- Shares outstanding 29.0M
- Free float 19.5M
Pharma Foods International Co., Ltd. company profile
- Company name
- Pharma Foods International Co., Ltd.
- Ticker
- PMDSF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 625
- Fiscal year end
- July
- Address
- 1-49 Goryo-Ohara, Kyoto, Japan, 615-8245
- Phone
- 81 75 394 8600
- Website
- pharmafoods.co.jp
About Pharma Foods International Co., Ltd.
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. It also focuses on biomedical drug discovery of antibody and peptide drugs targeting diseases, including autoimmune, cancer, and inflammatory. The company was founded in 1997 and is headquartered in Kyoto, Japan.
Pharma Foods International Co., Ltd. management
6- Dr. Mu Jo KimCEO, President & Representative Director · born 1947
- Mr. Kazuyuki MasudaSenior MD, Group Mgmt Head & Mail Order Business, President of Pharma Foods Communication & Director · born 1976
- Mr. Yong-il KimDirector of Research & Development and Director · born 1981
- Mr. Hirotaka HigashiyamaDirector of Management Department & Director · born 1975
- Mr. Masao NawanoVice President of R&D Division & Director · born 1976
- Mr. Kosuke TorioExecutive Officer & Director · born 1976